Global Sepsis Diagnostic Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product;

Instruments, Assays and Reagents, and Other.

By Pathogen;

Bacterial Sepsis, Fungal Sepsis, and Other.

By Technology;

Molecular Diagnostics, Microbiology, Immunoassay, and Other.

By Method;

Conventional Diagnostics, and Automated Diagnostics.

By End-Use;

Hospitals, and Pathology Laboratories.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn589833327 Published Date: March, 2025 Updated Date: May, 2025

Introduction

Global Sepsis Diagnostic Market (USD Million), 2021 - 2031

In the year 2024, the Global Sepsis Diagnostic Market was valued at USD 655.97 million. The size of this market is expected to increase to USD 1,164.17 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 8.5%.

Market Growth Driven by Sepsis Incidence and Rapid Diagnosis Needs:
The global sepsis diagnostics market is witnessing robust growth, driven by the alarming rise in sepsis cases and the urgent need for faster, more accurate diagnostic tools. Sepsis—a critical condition triggered by the body’s extreme reaction to infection—accounts for nearly 20% of global deaths, making early detection a public health priority. Growing awareness among clinicians and healthcare stakeholders has intensified the demand for rapid diagnostic solutions, with a strong push toward precision medicine to quickly identify the pathogens responsible and initiate timely treatment.

Technological Innovations Reshaping Diagnostics:
Technological innovations are fundamentally transforming the sepsis diagnostic landscape. Advanced modalities such as biomarker-based assays, molecular diagnostics are significantly enhancing diagnostic speed and accuracy. Notably, biomarker-based methods now comprise around 35% of all sepsis diagnostic approaches. Meanwhile, molecular techniques—including polymerase chain reaction (PCR) and genomic sequencing—are gaining traction due to their high sensitivity and specificity. The adoption of POC devices is also accelerating, particularly in emergency departments and intensive care units, where reducing diagnostic turnaround time is vital to improving patient outcomes.

AI Integration and Multiplex Testing Enhance Efficiency:
The market is benefiting from the integration of automation and artificial intelligence (AI) in clinical diagnostics. AI-powered platforms are expected to boost testing efficiency by up to 40%, streamlining decision-making and expediting pathogen detection. Laboratories are also adopting multiplex diagnostic systems, which allow simultaneous identification of various pathogens and biomarkers, thereby minimizing delays and enhancing workflow efficiency. As healthcare systems combat the dual challenges of hospital-acquired infections and antimicrobial resistance, the demand for innovative sepsis diagnostic technologies is set to rise significantly in the years ahead.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Pathogen
    3. Market Snapshot, By Technology
    4. Market Snapshot, By Method
    5. Market Snapshot, By End-Use
    6. Market Snapshot, By Region
  4. Global Sepsis Diagnostic Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Technological Advancements
        2. Rising Incidence of Sepsis
        3. Growing Emphasis on Early Diagnosis
      2. Restraints
        1. Lack of Awareness
        2. High Cost of Diagnostic Tests
        3. Regulatory Challenges
      3. Opportunities
        1. Emerging Markets
        2. Point-of-Care Testing
        3. Collaborative Research Efforts
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Compititive Rivalry
  5. Market Segmentation
    1. Global Sepsis Diagnostic Market, By Product, 2021 - 2031 (USD Million)
      1. Instruments
      2. Assays and Reagents
      3. Other
    2. Global Sepsis Diagnostic Market, By Pathogen, 2021 - 2031 (USD Million)
      1. Bacterial Sepsis
      2. Fungal Sepsis
      3. Other
    3. Global Sepsis Diagnostic Market, By Technology, 2021 - 2031 (USD Million)
      1. Molecular Diagnostics
      2. Microbiology
      3. Immunoassay
      4. Other
    4. Global Sepsis Diagnostic Market, By Method, 2021 - 2031 (USD Million)
      1. Conventional Diagnostics
      2. Automated Diagnostics
    5. Global Sepsis Diagnostic Market, By End-Use, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Pathology Laboratories
    6. Global Sepsis Diagnostic Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Abbott
      2. Axis-Shield Diagnostics
      3. Biomrieux
      4. Becton Dickinson
      5. Bruker
      6. Cytosorbents
      7. Danaher
      8. Immunexpress
      9. Luminex
      10. Roche
  7. Analyst Views
  8. Future Outlook of the Market